137 related articles for article (PubMed ID: 2428880)
1. Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.
Copeland TD; Tsai WP; Kim YD; Oroszlan S
J Immunol; 1986 Nov; 137(9):2945-51. PubMed ID: 2428880
[TBL] [Abstract][Full Text] [Related]
2. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
3. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
4. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
5. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.
Chen YM; Zhang XQ; Dahl CE; Samuel KP; Schooley RT; Essex M; Papas TS
J Immunol; 1991 Oct; 147(7):2368-76. PubMed ID: 1717557
[TBL] [Abstract][Full Text] [Related]
6. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
7. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
9. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
[TBL] [Abstract][Full Text] [Related]
10. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
[TBL] [Abstract][Full Text] [Related]
11. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
12. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of a C-terminal linear epitope highly conserved among the major envelope glycoprotein E2 (gp51 to gp54) of different pestiviruses.
Yu M; Wang LF; Shiell BJ; Morrissy CJ; Westbury HA
Virology; 1996 Aug; 222(1):289-92. PubMed ID: 8806512
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
15. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
Ohta M; Ohta K; Mori F; Nishitani H; Saida T
J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
[TBL] [Abstract][Full Text] [Related]
16. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
[TBL] [Abstract][Full Text] [Related]
18. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR
Science; 1986 Mar; 231(4745):1556-9. PubMed ID: 3006246
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.
Norrby E; Biberfeld G; Chiodi F; von Gegerfeldt A; Nauclér A; Parks E; Lerner R
Nature; 1987 Sep 17-23; 329(6136):248-50. PubMed ID: 3041232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
